treatment

May 22, 2019 by in CARDIOLOGY Comments Off on treatment

8 Non-pharmacological management Implantable cardiac defibrillators Death from heart failure (HF) is usually related to pump failure or ventricular arrhythmia (Figure 8.1). Left ventricular ejection fraction (LVEF) is the major…

read more

Diagnosis

May 22, 2019 by in CARDIOLOGY Comments Off on Diagnosis

5 Diagnosis Case history A 67-year-old man with diabetes mellitus, hypertension and renal impairment is referred to the cardiology outpatient department because of fatigue. He is overweight and relatively inactive,…

read more

Causes

May 22, 2019 by in CARDIOLOGY Comments Off on Causes

3 Causes In the majority of patients with chronic heart failure (HF), clinical deterioration is caused by one factor or a combination of factors (Table 3.1). In de novo cases…

read more

treatment

May 22, 2019 by in CARDIOLOGY Comments Off on treatment

7 Pharmacological treatment The different forms of heart failure (HF) (systolic and diastolic, left and right ventricular ([LV/RV] dysfunction, acute and chronic – see Chapter 1) require somewhat different treatment…

read more

and epidemiology

May 22, 2019 by in CARDIOLOGY Comments Off on and epidemiology

1 Definitions and epidemiology Definitions The term ‘heart failure’ (HF) is generally used to describe the physiological state in which cardiac function is insufficient to meet the metabolic needs of…

read more

and clinical stages

May 22, 2019 by in CARDIOLOGY Comments Off on and clinical stages

2 Pathophysiology and clinical stages Pathophysiology Advances in the management of heart failure (HF) over the past 20 years have been informed by a better understanding of its pathophysiology. There…

read more

Prognosis

May 22, 2019 by in CARDIOLOGY Comments Off on Prognosis

9 Prognosis Diagnosis of heart failure (HF) carries a poor prognosis, often comparable with that of cancer. The annual mortality for mild-to-moderate HF (NYHA class II or III) is 24–28%,…

read more

trials and developments

May 22, 2019 by in CARDIOLOGY Comments Off on trials and developments

10 Clinical trials and developments Stem cell therapy Stem cell therapy remains a promising treatment for patients with left ventricular (LV) dysfunction caused by coronary ischemia/infarction. Intracoronary or intramyocardial injections…

read more

Comorbidities

May 22, 2019 by in CARDIOLOGY Comments Off on Comorbidities

4 Comorbidities Anemia Anemia (hemoglobin < 130 g/L in men, and < 120 g/L in women) is common in patients with heart failure (HF). It is associated with poorer outcomes…

read more

management and lifestyle considerations

May 22, 2019 by in CARDIOLOGY Comments Off on management and lifestyle considerations

6 General management and lifestyle considerations Multidisciplinary strategies The cost of managing patients with heart failure (HF) is substantial and continues to grow, with the main area of expenditure being…

read more
Get Clinical Tree app for offline access